M3NetFlow: A Novel Multi-scale Multi-hop Graph AI Model for Integrative Multi-omic Data Analysis

Overview

Journal bioRxiv

Date 2024 Sep 16

PMID 39282437

Authors

Heming Zhang

S Peter Goedegebuure

Li Ding

David DeNardo

Ryan C Fields

Yixin Chen

Philip Payne

Fuhai Li

Affiliations

Soon will be listed here.

Abstract

Multi-omic data-driven studies, characterizing complex disease signaling system from multiple levels, are at the forefront of precision medicine and healthcare. The integration and interpretation of multi-omic data are essential for identifying molecular targets and deciphering core signaling pathways of complex diseases. However, it remains an open problem due the large number of biomarkers and complex interactions among them. In this study, we propose a novel Multi-scale Multi-hop Multi-omic graph model, , to facilitate generic multi-omic data analysis to rank targets and infer core signaling flows/pathways. To evaluate M3NetFlow, we applied it in two independent multi-omic case studies: 1) uncovering mechanisms of synergistic drug combination response (defined as anchor-target guided learning), and 2) identifying biomarkers and pathways of Alzheimer 's disease (AD). The evaluation and comparison results showed achieves the best prediction accuracy (accurate), and identifies a set of essential targets and core signaling pathways (interpretable). The model can be directly applied to other multi-omic data-driven studies. The code is publicly accessible at: https://github.com/FuhaiLiAiLab/M3NetFlow.

References

Mihajlovic K, Ceddia G, Malod-Dognin N, Novak G, Kyriakis D, Skupin A . Multi-omics integration of scRNA-seq time series data predicts new intervention points for Parkinson's disease. Sci Rep. 2024; 14(1):10983. PMC: 11094121. DOI: 10.1038/s41598-024-61844-3. View

Nikolentzos G, Dasoulas G, Vazirgiannis M . k-hop graph neural networks. Neural Netw. 2020; 130:195-205. DOI: 10.1016/j.neunet.2020.07.008. View

Malumbres M, Barbacid M . RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003; 3(6):459-65. DOI: 10.1038/nrc1097. View

Nistri S, Bani D . Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease. Curr Neurovasc Res. 2005; 2(3):225-3. DOI: 10.2174/1567202054368362. View

Deelen J, Evans D, Arking D, Tesi N, Nygaard M, Liu X . A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat Commun. 2019; 10(1):3669. PMC: 6694136. DOI: 10.1038/s41467-019-11558-2. View

Neff R, Wang M, Vatansever S, Guo L, Ming C, Wang Q . Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv. 2021; 7(2. PMC: 7787497. DOI: 10.1126/sciadv.abb5398. View

Preuer K, Lewis R, Hochreiter S, Bender A, Bulusu K, Klambauer G . DeepSynergy: predicting anti-cancer drug synergy with Deep Learning. Bioinformatics. 2017; 34(9):1538-1546. PMC: 5925774. DOI: 10.1093/bioinformatics/btx806. View

Braak H, Del Tredici K . The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. Brain. 2015; 138(Pt 10):2814-33. DOI: 10.1093/brain/awv236. View

Wishart D, Feunang Y, Guo A, Lo E, Marcu A, Grant J . DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017; 46(D1):D1074-D1082. PMC: 5753335. DOI: 10.1093/nar/gkx1037. View

10.

Zagidullin B, Aldahdooh J, Zheng S, Wang W, Wang Y, Saad J . DrugComb: an integrative cancer drug combination data portal. Nucleic Acids Res. 2019; 47(W1):W43-W51. PMC: 6602441. DOI: 10.1093/nar/gkz337. View

11.

Wang T, Shao W, Huang Z, Tang H, Zhang J, Ding Z . MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat Commun. 2021; 12(1):3445. PMC: 8187432. DOI: 10.1038/s41467-021-23774-w. View

12.

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

13.

Sweatt J . Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol. 2004; 14(3):311-7. DOI: 10.1016/j.conb.2004.04.001. View

14.

Talbot K . Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs. Neurodegener Dis Manag. 2014; 4(1):31-40. PMC: 4465775. DOI: 10.2217/nmt.13.73. View

15.

Munoz L, Ammit A . Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology. 2009; 58(3):561-8. DOI: 10.1016/j.neuropharm.2009.11.010. View

16.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

17.

Li X, Ma J, Leng L, Han M, Li M, He F . MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis. Front Genet. 2022; 13:806842. PMC: 8847688. DOI: 10.3389/fgene.2022.806842. View

18.

Glass C, Saijo K, Winner B, Marchetto M, Gage F . Mechanisms underlying inflammation in neurodegeneration. Cell. 2010; 140(6):918-34. PMC: 2873093. DOI: 10.1016/j.cell.2010.02.016. View

19.

Vaske C, Benz S, Sanborn J, Earl D, Szeto C, Zhu J . Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010; 26(12):i237-45. PMC: 2881367. DOI: 10.1093/bioinformatics/btq182. View

20.

Stark C, Breitkreutz B, Reguly T, Boucher L, Breitkreutz A, Tyers M . BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2005; 34(Database issue):D535-9. PMC: 1347471. DOI: 10.1093/nar/gkj109. View